## Gene Summary
FAM13A, short for 'Family with sequence similarity 13 member A', is a gene encoding a protein that is involved in the regulation of signaling pathways related to Rho GTPases, key elements that contribute to various cellular functions including stress fiber formation, cytoskeletal rearrangement, and cell migration. FAM13A expression is particularly notable in the lungs, and it has been implicated in the regulation of processes such as cell adhesion and intracellular signal transduction.

## Gene Drugs, Diseases, Phenotypes, and Pathways
FAM13A is not primarily known for its direct involvement with specific drugs, but it has been repeatedly associated with several lung-related diseases, most notably chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis. The role of FAM13A in these diseases is believed to be connected to its influence on cell structure and response to oxidative stress. Genetic variations in FAM13A have also been linked to lung cancer susceptibility and asthma severity, suggesting its broader role in pulmonary pathophysiology. Additionally, FAM13A participates in pathways that affect beta-catenin signalingâ€”a critical pathway in the development and disease processes of various tissues.

## Pharmacogenetics
In pharmacogenetics, research surrounding FAM13A mostly centers on its implications in disease susceptibility and progression rather than direct interactions with specific pharmaceutical agents. However, understanding the genetic variations in FAM13A can be crucial for developing targeted therapies aimed at modulating its activity, especially in diseases like COPD and pulmonary fibrosis. For these conditions, therapies that can adjust the signaling pathways influenced by FAM13A may prove beneficial and could be a point of interest for future pharmacogenetic research focused on enhancing treatment efficacy and personalizing medical approaches based on the genetic profiles involving the FAM13A gene.